Schroder Investment Management Group
TEVA icon

Schroder Investment Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Schroder Investment Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.3M Sell
2,280,484
-2,095,786
-48% -$69.8M 0.05% 255
2026
Q1 		$132M Sell
4,376,270
-3,050,615
-41% -$98.1M 0.11% 163
2025
Q4 		$232M Buy
7,426,885
+5,370,253
+261% +$132M 0.18% 104
2025
Q3 		$41.5M Buy
2,056,632
+1,064
+0.1% +$18.7K 0.03% 352
2025
Q2 		$34.5M Sell
2,055,568
-198,934
-9% -$3.21M 0.03% 392
2025
Q1 		$34M Buy
2,254,502
+24,716
+1% +$441K 0.03% 366
2024
Q4 		$49.8M Buy
2,229,786
+1,320,076
+145% +$24M 0.05% 297
2024
Q3 		$15.9M Sell
909,710
-117,600
-11% -$2.06M 0.02% 577
2024
Q2 		$16.7M Buy
1,027,310
+173,645
+20% +$2.67M 0.02% 515
2024
Q1 		$12M Buy
853,665
+246,076
+41% +$3.1M 0.01% 612
2023
Q4 		$6.34M Buy
+607,589
New +$5.67M 0.01% 721
2023
Q1 		– Sell
-37,178
Closed -$339K – 1323
2022
Q4 		$339K Buy
37,178
+14,779
+66% +$129K ﹤0.01% 1208
2022
Q3 		$181K Sell
22,399
-373,082
-94% -$3.3M ﹤0.01% 1240
2022
Q2 		$3.14M Sell
395,481
-313,845
-44% -$2.73M ﹤0.01% 889
2022
Q1 		$6.65M Buy
709,326
+6,499
+0.9% +$54.2K 0.01% 768
2021
Q4 		$5.63M Sell
702,827
-22,412
-3% -$202K 0.01% 730
2021
Q3 		$7.06M Buy
725,239
+1,969
+0.3% +$18.4K 0.01% 703
2021
Q2 		$7.16M Buy
723,270
+692,127
+2,222% +$7.33M 0.01% 754
2021
Q1 		$359K Buy
+31,143
New +$357K ﹤0.01% 1278
2020
Q2 		– Sell
-1,488
Closed -$14K – 1332
2020
Q1 		$14K Buy
+1,488
New +$15.2K ﹤0.01% 1271
2019
Q4 		– Sell
-283,811
Closed -$1.96M – 1340
2019
Q3 		$1.96M Buy
+283,811
New +$2.17M ﹤0.01% 887
2018
Q4 		– Sell
-1,264,695
Closed -$27.2M – 1297
2018
Q3 		$27.2M Sell
1,264,695
-315,800
-20% -$7.33M 0.05% 422
2018
Q2 		$39.1M Sell
1,580,495
-536,600
-25% -$10.9M 0.07% 318
2018
Q1 		$36.2M Sell
2,117,095
-2,280,916
-52% -$44.5M 0.06% 336
2017
Q4 		$83.3M Sell
4,398,011
-1,796,072
-29% -$27M 0.14% 194
2017
Q3 		$106M Buy
6,194,083
+1,147,683
+23% +$25.8M 0.18% 132
2017
Q2 		$166M Buy
5,046,400
+478,971
+10% +$14.8M 0.3% 69
2017
Q1 		$149M Sell
4,567,429
-145,703
-3% -$4.97M 0.27% 85
2016
Q4 		$171M Sell
4,713,132
-4,111,963
-47% -$164M 0.33% 63
2016
Q3 		$406M Buy
8,825,095
+1,170,362
+15% +$61.1M 0.76% 21
2016
Q2 		$384M Buy
7,654,733
+2,375,340
+45% +$126M 0.77% 21
2016
Q1 		$287M Buy
5,279,393
+1,454,295
+38% +$85.3M 0.59% 31
2015
Q4 		$251M Buy
3,825,098
+2,417,277
+172% +$149M 0.52% 38
2015
Q3 		$79.5M Buy
1,407,821
+79,685
+6% +$5.17M 0.17% 154
2015
Q2 		$78.9M Buy
1,328,136
+66,468
+5% +$4.1M 0.16% 176
2015
Q1 		$78.2M Buy
1,261,668
+407,456
+48% +$23.7M 0.15% 178
2014
Q4 		$49.1M Sell
854,212
-714,147
-46% -$39.8M 0.1% 256
2014
Q3 		$84.3M Sell
1,568,359
-264,904
-14% -$14M 0.11% 170
2014
Q2 		$96.1M Sell
1,833,263
-2,193,600
-54% -$112M 0.12% 163
2014
Q1 		$213M Sell
4,026,863
-524,913
-12% -$24.3M 0.24% 78
2013
Q4 		$182M Sell
4,551,776
-497,924
-10% -$19.6M 0.23% 84
2013
Q3 		$191M Buy
5,049,700
+1,702,033
+51% +$66.4M 0.46% 44
2013
Q2 		$131M Buy
+3,347,667
New +$130M 0.35% 68

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Schroder Investment Management Group's TEVA Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Teva Pharmaceuticals (TEVA) stake by 48% in Q2 2026, selling an estimated $69.8M and leaving 2,280,484 shares worth $77.3M. The position accounts for 0.05% of the portfolio, ranked #255.

Schroder Investment Management Group first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $406M in Q3 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Schroder Investment Management Group held 2,280,484 shares of Teva Pharmaceuticals worth $77.3M as of Q2 2026.
  • Schroder Investment Management Group sold 2,095,786 Teva Pharmaceuticals shares in Q2 2026, an estimated $69.8M.
  • Teva Pharmaceuticals made up 0.05% of Schroder Investment Management Group's portfolio in Q2 2026, its #255 holding.
  • Schroder Investment Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
  • Schroder Investment Management Group's Teva Pharmaceuticals position peaked at $406M in Q3 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.